A pandemic study regarding the long term effects of Covid-19 in its survivors has estimated that 1 in 3 individuals were diagnosed with neurological or psychiatric conditions within six months of their initial infection.
The study was published this week in the peer-reviewed journal, The Lancet Psychiatry. The study itself used electronic health records from more than 230,000 Covid-19 patients mainly from the US and specifically regarding 14 different brain and mental health disorders.
The study found that “34% of survivors were diagnosed with at least one of the 14 conditions, with 13% of those people being their first recorded neurological or psychiatric diagnosis. Mental health diagnoses were most common among patients, with 17% diagnosed with anxiety and 14% diagnosed with a mood disorder.”
Neurological diagnoses were much more uncommon, however, they were more prevalent in patients who experienced serious illness during their Covid-19 infection. 7% of Covid-19 patients who had to be admitted to intensive care had a stroke, for example, and 2% were diagnosed with dementia.
“It shows the toll that COVID takes is not just with the (disease itself), but also with the aftermath of the condition, which can be extremely complicated, involving not only the brain but other organs in the body as well,” said Dr. William Li, president and medical director of the Angiogenesis Foundation, a nonprofit dedicated to the study of abnormal blood vessel growth.
The study also looked at around 100,000 flu patients and more than 230,000 patients who were diagnosed with a respiratory tract infection within the past year and found that neurological and psychiatric diagnoses were more common in individuals who fought Covid-19.
“There was a 44% greater risk of brain or mental health disorder diagnoses after COVID-19 than after the flu, and a 16% greater risk than with respiratory tract infections,” according to the study.
Julie Walsh-Messinger, assistant professor in the department of psychology at the University of Dayton, recently discussed how it’s possible that “coronavirus infection could lead to anxiety or depression as these conditions have been associated with inflammation typically seen in Covid-19.”
“We’re seeing higher rates of depression and anxiety across the board regardless of (COVID-19 infection) or not. It’s hard to tease apart how much of it is general stress-induced anxiety or depression because of lack of ability to socialize, lack of ability to engage in activities that one normally enjoys, fear about the future and how much of it is specific to the disease’s progress. Even so, the study is an important first step in what clinicians can expect from their patients who have recovered from COVID-19,” she explained.
“The size of the study also demonstrates how the long-term effects of COVID-19 can impact a country’s health care system even after the disease is gone. Although the individual risks for most disorders are small, the effect across the whole population may be substantial for health and social care systems due to the scale of the pandemic. Health care systems need to be resourced to deal with the anticipated need,” said lead author Paul Harrison, a professor at the University of Oxford in the U.K.
Eric Mastrota is a Contributing Editor at The National Digest based in New York. A graduate of SUNY New Paltz, he reports on world news, culture, and lifestyle. You can reach him at email@example.com.